Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition ; volume:41 ; number:40 ; day:6 ; month:9 ; year:2022 ; pages:4560-4572 ; date:9.2022
Oncogene ; 41, Heft 40 (6.9.2022), 4560-4572, 9.2022
- Urheber
-
Winkler, René
Mägdefrau, Ann-Sophie
Piskor, Eva-Maria
Kleemann, Markus
Beyer, Mandy
Linke, Kevin
Hansen, Lisa
Schaffer, Anna-Maria
Hoffmann, Marina E.
Poepsel, Simon
Heyd, Florian
Beli, Petra
Möröy, Tarik
Mahboobi, Siavosh
Krämer, Oliver Holger
Kosan, Christian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-022-02450-3
- URN
-
urn:nbn:de:101:1-2022121809062500072318
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Winkler, René
- Mägdefrau, Ann-Sophie
- Piskor, Eva-Maria
- Kleemann, Markus
- Beyer, Mandy
- Linke, Kevin
- Hansen, Lisa
- Schaffer, Anna-Maria
- Hoffmann, Marina E.
- Poepsel, Simon
- Heyd, Florian
- Beli, Petra
- Möröy, Tarik
- Mahboobi, Siavosh
- Krämer, Oliver Holger
- Kosan, Christian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
B-cell receptor driven MALT1 activity regulates c-MYC signaling in mantle cell lymphoma
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells
B-cell receptor driven MALT1 activity regulates c-MYC signaling in mantle cell lymphoma
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma
Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)
PICH deficiency limits the progression of MYC-induced B-cell lymphoma
Recalcitrant Subcutaneous Panniculitis-Like T-Cell Lymphoma Responsive to Histone Deacetylase Inhibitor
Histone deacetylase 6 in cancer
High-grade B-cell lymphoma with MYC and BCL2 rearrangements arising in a composite lymphoma
Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential
Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma
The effects of a histone deacetylase inhibitor on biological behavior of diffuse large B-cell lymphoma cell lines and insights into the underlying mechanisms
Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
Histone deacetylase 6 activity is critical for the metastasis of Burkitt’s lymphoma cells